Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Diphencyprone helped most patients with alopecia areata regrow some hair.

The excimer laser may help hair regrow in alopecia areata patients.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Adalimumab helped control a child's severe eye disease when other treatments failed.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Topical cyclosporin-A is recommended for severe alopecia areata.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

CD34+ cells decrease in bald areas, while Sox9 stays high, suggesting hair loss in AGA is linked to stem cell issues.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Alopecia areata is an autoimmune disease that targets hair follicles.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Cell detachment, not autoantibody binding, causes major changes in pemphigus.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.